BRIEF published on 12/16/2024 at 07:35, 1 year 10 months ago Circus et Vytal forment un partenariat pour un emballage durable en robotique Économie Circulaire Emballage Durable Partenariat Mondial Robotique IA Réduction Du Gaspillage Alimentaire
BRIEF published on 12/16/2024 at 07:17, 1 year 10 months ago All for One Group SE: Financial Growth and Sustainability Highlights for 2023/24 Dividend Increase All For One Group SE Financial Growth Sustainability Initiatives Future Outlook
BRIEF published on 12/16/2024 at 07:17, 1 year 10 months ago All for One Group SE : Faits marquants en matière de croissance financière et de durabilité pour 2023/24 Croissance Financière Perspectives D'avenir Augmentation Des Dividendes Groupe SE Tous Pour Un Initiatives En Matière De Développement Durable
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago PolyPeptide Group Launches New SPPS Capacity in Belgium Sustainability PolyPeptide Group SPPS Facility Belgium Production Pharmaceutical Investment
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago PolyPeptide Group lance une nouvelle capacité SPPS en Belgique Durabilité Groupe De PolyPeptides Installation SPPS Production Belge Investissement Pharmaceutique
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago Xlife Sciences AG Announces VERAXA Biotech's Planned NASDAQ Listing Nasdaq Listing Cancer Therapies VERAXA Biotech Biopharmaceutical Growth Xlife Sciences Strategy
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago Xlife Sciences AG annonce l'introduction en bourse de VERAXA Biotech au NASDAQ Cotation Au Nasdaq Thérapies Contre Le Cancer VERAXA Biotech Croissance Biopharmaceutique Stratégie De Xlife Sciences
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago Relief Therapeutics Reports Promising Outcomes from PKU GOLIKE Trial Biopharmaceutical Clinical Trial PKU GOLIKE Phenylketonuria Metabolic Control
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago Relief Therapeutics annonce des résultats prometteurs de l'essai GOLIKE sur la PKU Biopharmaceutique Essai Clinique PKU GOLIKE Phénylcétonurie Contrôle Métabolique
BRIEF published on 12/16/2024 at 07:05, 1 year 10 months ago Andrea Kleiner nommée responsable Clients entreprises chez Baloise Stratégie Assurance Transformation Numérique Nomination Baloise
Published on 10/30/2026 at 15:30, 3 hours 1 minute ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 12:20, 6 hours 11 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 6 hours 31 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/29/2026 at 22:01, 20 hours 30 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/30/2026 at 18:05, 26 minutes ago lePERMISLIBRE divise par trois sa perte d’exploitation au premier semestre 2026
Published on 10/30/2026 at 18:00, 31 minutes ago FLORENTAISE: Chiffre d’affaires du 1er trimestre 2026-2027 / Décalage de la publication des résultats annuels 2025-2026
Published on 10/30/2026 at 17:45, 46 minutes ago FORVIA HELLA presents financial results for the first nine months of 2026
Published on 10/30/2026 at 18:00, 31 minutes ago Laboratoires Euromedis - Communiqué résultat semestriel 2026
Published on 10/30/2026 at 18:00, 31 minutes ago Résultats du 1er semestre 2026 et chiffre d'affaires du 3ème trimestre 2026
Published on 10/30/2026 at 18:00, 31 minutes ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2026
Published on 10/30/2026 at 17:45, 46 minutes ago Déclaration au titre de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers
